Medtronic

Investing.com — Shares of Medtronic plc (NYSE:) climbed 3% after the company announced that the Centers for Medicare & Medicaid Services (CMS) has initiated a national coverage analysis (NCA) for its Symplicity Spyral Renal Denervation System, a device designed to treat patients with hypertension. The announcement was made by Medtronic,…